| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0902916.6AGB0902916D0 (en) | 2009-02-20 | 2009-02-20 | Antibody therapy |
| PCT/GB2010/050304WO2010094981A2 (en) | 2009-02-20 | 2010-02-22 | Antibody therapy |
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0902916.6AGB0902916D0 (en) | 2009-02-20 | 2009-02-20 | Antibody therapy |
| Publication Number | Publication Date |
|---|---|
| GB0902916D0true GB0902916D0 (en) | 2009-04-08 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0902916.6ACeasedGB0902916D0 (en) | 2009-02-20 | 2009-02-20 | Antibody therapy |
| Country | Link |
|---|---|
| GB (1) | GB0902916D0 (en) |
| WO (1) | WO2010094981A2 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9932402B2 (en)* | 2011-10-27 | 2018-04-03 | Nkt Therapeutics Inc. | Humanized antibodies to iNKT |
| CN114989297B (en)* | 2022-06-14 | 2022-10-25 | 北京科跃中楷生物技术有限公司 | Kit comprising horseradish peroxidase-labeled antibody |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5057313A (en) | 1986-02-25 | 1991-10-15 | The Center For Molecular Medicine And Immunology | Diagnostic and therapeutic antibody conjugates |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US5283187A (en) | 1987-11-17 | 1994-02-01 | Brown University Research Foundation | Cell culture-containing tubular capsule produced by co-extrusion |
| US4892538A (en) | 1987-11-17 | 1990-01-09 | Brown University Research Foundation | In vivo delivery of neurotransmitters by implanted, encapsulated cells |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| DE3920358A1 (en) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | BISPECIFIC AND OLIGO-SPECIFIC, MONO- AND OLIGOVALENT ANTI-BODY CONSTRUCTS, THEIR PRODUCTION AND USE |
| GB8928874D0 (en) | 1989-12-21 | 1990-02-28 | Celltech Ltd | Humanised antibodies |
| EP0519596B1 (en) | 1991-05-17 | 2005-02-23 | Merck & Co. Inc. | A method for reducing the immunogenicity of antibody variable domains |
| ES2136092T3 (en) | 1991-09-23 | 1999-11-16 | Medical Res Council | PROCEDURES FOR THE PRODUCTION OF HUMANIZED ANTIBODIES. |
| ES2241710T3 (en) | 1991-11-25 | 2005-11-01 | Enzon, Inc. | PROCEDURE TO PRODUCE MULTIVALENT PROTEINS FROM UNION TO ANTIGEN. |
| AU4528493A (en) | 1992-06-04 | 1994-01-04 | Regents Of The University Of California, The | In vivo gene therapy with intron-free sequence of interest |
| US5639641A (en) | 1992-09-09 | 1997-06-17 | Immunogen Inc. | Resurfacing of rodent antibodies |
| US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
| NZ563273A (en) | 2005-04-09 | 2010-02-26 | Fusion Antibodies Ltd | Cathepsin S antibody |
| GB0620255D0 (en) | 2006-10-12 | 2006-11-22 | Fusion Antibodies Ltd | Antibody and uses thereof |
| Publication number | Publication date |
|---|---|
| WO2010094981A2 (en) | 2010-08-26 |
| WO2010094981A3 (en) | 2010-12-23 |
| Publication | Publication Date | Title |
|---|---|---|
| HRP20180952T1 (en) | Anti-dll3 antibody | |
| IL214996A0 (en) | Anti-bcma antibodies | |
| GB0920127D0 (en) | Antibodies | |
| ZA201104545B (en) | Anti-siglec-15 antibody | |
| GB0909906D0 (en) | Antibodies | |
| HUE040213T2 (en) | Anti-tim-3 antibody | |
| EP2569012A4 (en) | Anti-fgfr2 antibodies | |
| PL2616489T3 (en) | Anti-hutnfr1 antibody | |
| EP2427496A4 (en) | Anti-vegf-d antibodies | |
| GB0920324D0 (en) | Antibodies | |
| HK1170745A1 (en) | Antibodies against il-17br il-17br | |
| GB0815788D0 (en) | Therapeutic antibodies | |
| EP2499256A4 (en) | Anti-c-mpl antibodies | |
| GB2473934B (en) | Anti-VEEV antibody | |
| EP2324059A4 (en) | Anti-pamp therapeutic antibodies | |
| GB0916997D0 (en) | Combination therapy | |
| GB0902916D0 (en) | Antibody therapy | |
| GB0907973D0 (en) | Combination therapy | |
| GB201007957D0 (en) | Antibody | |
| GB0903321D0 (en) | Therapy | |
| GB0914820D0 (en) | WATerian therapy | |
| GB0903319D0 (en) | Therapy | |
| GB0921244D0 (en) | Therapy | |
| GB0911712D0 (en) | Antibody | |
| GB0908945D0 (en) | Antibodies |
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |